Cite
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
MLA
Fox, Kim, et al. “Ivabradine for Patients with Stable Coronary Artery Disease and Left-Ventricular Systolic Dysfunction (BEAUTIFUL): A Randomised, Double-Blind, Placebo-Controlled Trial.” Lancet, vol. 372, no. 9641, Sept. 2008, pp. 807–16. EBSCOhost, https://doi.org/10.1016/S0140-6736(08)61170-8.
APA
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008). Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet, 372(9641), 807–816. https://doi.org/10.1016/S0140-6736(08)61170-8
Chicago
Fox, Kim, Ian Ford, P. Gabriel Steg, Michal Tendera, and Roberto Ferrari. 2008. “Ivabradine for Patients with Stable Coronary Artery Disease and Left-Ventricular Systolic Dysfunction (BEAUTIFUL): A Randomised, Double-Blind, Placebo-Controlled Trial.” Lancet 372 (9641): 807–16. doi:10.1016/S0140-6736(08)61170-8.